Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix–loop–helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells

  1. Mohamed Boudjelal1,
  2. Reshma Taneja2,
  3. Shyuichiro Matsubara3,
  4. Philippe Bouillet4,
  5. Pascal Dollé, and
  6. Pierre Chambon5
  1. Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National de la Recherche Scientifique–Institut National de la Santé et de la Recherche Médicale–Université Louis Pasteur (CNRS–INSERM–ULP), Collège de France, 67404 Illkirch–Cedex, France

Abstract

We report the cDNA cloning of Stra13, a novel retinoic acid (RA)-inducible gene from P19 embryonal carcinoma cells that encodes a basic helix–loop–helix (bHLH) protein that shows the highest sequence similarities to the Drosophila Hairy and Enhancer of split and mouse Hes proteins. Stra13 does not bind to the known consensus motifs (E-box and N-box) for bHLH proteins, but can repress activated transcription (through an α-helix rich domain) in part by interaction with general factors of the basal transcription machinery. During mouse embryogenesis, Stra13 RNA is expressed in the neuroectoderm, and also in a number of mesodermal and endodermal derivatives. Remarkably, overexpression of Stra13 in P19 cells results in neuronal differentiation in monolayer culture, under conditions where wild-type P19 cells only undergo mesodermal/endodermal differentiation. This neuronal differentiation is accompanied by an altered expression of mesodermal and neuronal markers, indicating that Stra13 could be one of the earliest RA target genes whose expression is required for repression of mesodermal/endodermal differentiation and/or induction of neuronal differentiation when P19 cell aggregates are exposed to RA. Our results raise the possibility that Stra13 could be involved as a repressor in a number of decision events occurring during differentiation of various cell lineages.

Keywords

Footnotes

  • Present addresses: 1University of Michigan, Dermatology Research, Ann Arbor, Michigan 48109-0609 USA; 2Department of Medicine, The Mount Sinai School of Medicine, New York, New York 10029-6574 USA; 3Department of Biochemistry, Kagoshima University Faculty of Medicine, Kagoshima, 890 Japan; 4Molecular Biology Unit, The Walter & Eliza Hall Institute of Medical Research, Victoria 3050, Australia.

  • 5 Corresponding author.

  • E-MAIL igbmc{at}igbmc.u-strasbg.fr; FAX (33) 88 65 32 03.

    • Received April 28, 1997.
    • Accepted June 30, 1997.
| Table of Contents

Life Science Alliance